Opioid prescription and diabetes among Medicare beneficiaries.

Autor: Casagrande SS; Social & Scientific Systems, Inc., Department of Health Services Research, Silver Spring, MD, United States. Electronic address: Sarah.casagrande@dlhcorp.com., Beccera AZ; Social & Scientific Systems, Inc., Department of Health Services Research, Silver Spring, MD, United States; Rush University, Department of Surgery, Rush Medical College, Chicago, IL, United States., Rust KF; Westat, Rockville, MD, United States., Cowie CC; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
Jazyk: angličtina
Zdroj: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2023 Feb; Vol. 196, pp. 110240. Date of Electronic Publication: 2023 Jan 04.
DOI: 10.1016/j.diabres.2023.110240
Abstrakt: Aims: To determine the prevalence of opioid prescriptions among U.S. Medicare beneficiaries by diabetes status, and predictors of opioid prescription among those with diabetes.
Methods: This retrospective study used claims data from the Centers for Medicare and Medicaid Services among beneficiaries age ≥ 65 years who were continuously enrolled in Part A, Part B, and Part D Medicare between 2017 and 2019 (N = 709,374). Logistic regression was used to determine the odds of opioid prescription among those with vs without diabetes; and, among those with diabetes, significant predictors of opioid prescription.
Results: Overall, the prevalence of any opioid prescription was 30.8 % among persons with diabetes and 24.2 % in those without diabetes (p < 0.001); chronic use was 8.0 % and 7.4 %, respectively (p < 0.001). Those with diabetes had a 45 % higher odds of having an opioid prescription compared to those without diabetes after adjusting for sociodemographic characteristics (OR = 1.45, 1.44-1.47). After adjustment for comorbidities/complications, the association reversed (OR = 0.83, 0.82-0.84). Persons with diabetes who had hypertension, obesity, CVD, neuropathy, amputation, liver disease, COPD, cancer, osteoporosis, depression, or alcohol/drug abuse had a 20 %-140 % higher odds of opioid prescription compared to those without these conditions.
Conclusions: Comorbidities and complications accounted for the higher odds of opioid prescriptions among those with diabetes.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: